These metabolic disturbances, such as insulin resistance and dyslipidemia, may exacerbate bone loss by promoting chronic inflammation and altering adipokine secretion (e.g., reduced adiponectin),31 potentially explaining the stronger association between BF% obesity and osteopenia observed in the female subgroup. Here, ADIPOQ is linked to Osteopenia.